Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
United Allergy Services has provided more than 575,000 allergy tests and over 36 million immunotherapy treatments to more than 350,000 patients. Their proprietary protocols have demonstrated significant improvements in allergic rhinitis scores for 95% of patients; 82% reported reduced medication use; and 88% saw improved quality of life scores. Most patients experience substantial symptom relief within the first year of treatment[2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on United Allergy Services.